Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers
Clinical trial NCT04230408 · COMPLETED
Trial details
- NCT number
- NCT04230408
- Sponsor
- Latin American Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-05
- Primary completion
- 2024-10-07
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.